LINC02515: A Potential Drug Target or Biomarker (G102723920)

Target Name: LINC02515

NCBI ID: G102723920

LINC02515

Other Name(s): LINC02515 variant X1 | Long intergenic non-protein coding RNA 2515, transcript variant X1 | long intergenic non-protein coding RNA 2515

LINC02515: A Potential Drug Target or Biomarker

LINC02515 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LINC family of proteins, which are known for their role in regulating gene expression and cell signaling. LINC02515 has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The LINC02515 protein is composed of 216 amino acid residues and has a calculated molecular weight of 23.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is localized to the cytoplasm. LINC02515 is a protein that is involved in several cellular processes, including cell signaling, cell division, and inflammation.

One of the most significant functions of LINC02515 is its role in cell signaling. LINC02515 is a member of the T-cell signaling pathway, which is involved in the regulation of immune responses and cell signaling. LINC02515 has been shown to play a role in the regulation of T-cell development and function, including the regulation of helper T cells and the regulation of T-cell responses to antigens.

In addition to its role in cell signaling, LINC02515 is also involved in the regulation of cell division. LINC02515 has been shown to play a role in the regulation of cell division in various tissues, including the regulation of the growth and division of cancer cells.

LINC02515 is also involved in the regulation of inflammation. LINC02515 has been shown to play a role in the regulation of inflammation in various tissues, including the regulation of the inflammatory response to infection.

Due to its involvement in several cellular processes, LINC02515 has been identified as a potential drug target or biomarker for a variety of diseases. For example, LINC02515 has been shown to be a potential drug target for cancer, as it has been shown to play a role in the regulation of cancer cell growth and division. In addition, LINC02515 has also been shown to be a potential biomarker for neurodegenerative diseases, as it has been shown to be involved in the regulation of neurodegenerate diseases.

In conclusion, LINC02515 is a protein that is involved in several cellular processes and has been identified as a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of LINC02515 in these diseases and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 2515

The "LINC02515 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02515 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets